CryoHoldco is a stem cell bank holding company that is the market leader in Latin America and one of the top 10 largest cord blood banks in the world.
CryoHoldco is about five times larger (5X) than any other stem cell bank in Latin America—with more than 125,000 cord blood samples stored.
When cord tissue units are also included, it has more than 130,000 stem cell units in inventory. CryoHoldco was created in 2015 with the purpose of forming the premier stem cell banking company in Latin America.
The first asset that was acquired by CryoHoldco was Cryo-Cell Mexico, the first stem cell bank in Latin America.
Since investing in Cryo-Cell Mexico in mid 2015, CryoHoldco has been active in the market and has acquired a controlling interest in a regional stem cell bank in Mexico (Q4 of 2015), as well as acquired Stem Medicina Regenerativa (early 2016), the largest stem cell bank in Colombia.
CryoHoldco, Largest Cord Blood Bank in Latin America
Today, CryoHoldco represents the largest stem cell banking operation in Latin America.
The company features 130,000 stored cord blood and tissue samples, two state-of-the art lab and storage facilities in Mexico and Colombia, a growing network of 10,000+ affiliated doctors, and 100+ sales offices.
CryoHoldco’s state-of–the-art storage facility in Guadalajara, Mexico, has a capacity of 300,000 samples.
Finally, CryoHoldco has a diversified revenue stream and product offering, which includes: cord blood and cord tissue banking, as well as storage of mesenchymal cells derived from dental pulp. In 2016, the company is launching adipose tissue storage and a maternity bank. More details can be found in our interview with James Alexis Mendez, CFO of CryoHoldco.